Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 17 Feb 2023 08:00 CET |
VISTIN PHARMA | Vistin Pharma ASA: Fourth quarter and preliminary 2022 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 10 Feb 2023 10:00 CET |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q4 2022 conference call | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 14 Dec 2022 14:41 CET |
VISTIN PHARMA | Financial calendar | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Dec 2022 12:10 CET |
VISTIN PHARMA | Vistin Pharma enters into a long-term renewable energy supply agreement with Statkraft | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 26 Oct 2022 07:45 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Third quarter and YTD 2022 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 18 Oct 2022 14:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q3 2022 conference call | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 19 Aug 2022 07:50 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Second quarter and first half 2022 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 11 Aug 2022 13:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q2 2022 conference call | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 19 May 2022 11:50 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Minutes from the annual general meeting 2022 | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Apr 2022 13:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Notice of Annual General Meeting | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Apr 2022 13:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Annual Report for 2021 | 20103015 Pharmaceuticals | Annual financial and audit Reports |
| 27 Apr 2022 07:45 CEST |
VISTIN PHARMA | Vistin Pharma ASA: First quarter 2022 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 20 Apr 2022 13:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q1 2022 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Feb 2022 07:40 CET |
VISTIN PHARMA | Vistin Pharma ASA: Fourth quarter 2021 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 16 Feb 2022 15:45 CET |
VISTIN PHARMA | New interim CEO | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Feb 2022 14:00 CET |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q4 2021 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 14 Dec 2021 09:38 CET |
VISTIN PHARMA | Financial calendar | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 29 Oct 2021 14:39 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Mandatory notification of trade | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 29 Oct 2021 13:51 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Disclosure of large shareholding | 20103015 Pharmaceuticals | Major shareholding notifications |
| 28 Oct 2021 07:45 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Third quarter 2021 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 21 Oct 2021 12:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q3 2021 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 14 Sep 2021 08:34 CEST |
VISTIN PHARMA | Mandatory notification of trade in Vistin Pharma ASA | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 19 Aug 2021 07:45 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Second quarter and first half 2021 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 12 Aug 2021 13:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q2 2021 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 21 May 2021 08:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Ex dividend NOK 0.5 today | 20103015 Pharmaceuticals | Ex Date |
| 20 May 2021 14:55 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Minutes from the annual general meeting 2021 | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 19 May 2021 08:30 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Mandatory notification of trade | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 04 May 2021 08:50 CEST |
VISTIN PHARMA | CORRECTION: Vistin Pharma ASA : Key information relating to the cash dividend | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Apr 2021 11:22 CEST |
VISTIN PHARMA | Vistin Pharma ASA : Key information relating to the cash dividend to be paid by Vistin Pharma ASA | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Apr 2021 12:30 CEST |
VISTIN PHARMA | Vistin Pharma ASA : Call for annual general meeting | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Apr 2021 12:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Annual Report for 2020 | 20103015 Pharmaceuticals | Annual financial and audit Reports |
| 23 Apr 2021 07:45 CEST |
VISTIN PHARMA | Vistin Pharma ASA: First quarter 2021 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 16 Apr 2021 15:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q1 2021 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Mar 2021 08:30 CET |
VISTIN PHARMA | Vistin Pharma ASA: Mandatory notification of trade | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 15 Mar 2021 16:31 CET |
VISTIN PHARMA | Vistin Pharma ASA: Mandatory notification of trade | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 15 Mar 2021 16:26 CET |
VISTIN PHARMA | Vistin Pharma ASA: Mandatory notification of trade | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 15 Mar 2021 15:10 CET |
VISTIN PHARMA | Disclosure of large shareholding in Vistin Pharma ASA | 20103015 Pharmaceuticals | Major shareholding notifications |
| 15 Mar 2021 13:51 CET |
VISTIN PHARMA | Flaggemelding - VISTIN PHARMA AS | 20103015 Pharmaceuticals | Flagging |
| 19 Feb 2021 07:55 CET |
VISTIN PHARMA | Vistin Pharma ASA: Fourth quarter and preliminary 2020 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 12 Feb 2021 14:30 CET |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q4 2020 conference call | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 05 Jan 2021 12:45 CET |
Vistin Pharma | Vistin Pharma ASA: Mandatory notification of trade | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 15 Dec 2020 12:26 CET |
Vistin Pharma | Finansiell kalender | 20103015 Pharmaceuticals | Annen informasjonspliktig regulatorisk informasjon |
| 15 Dec 2020 12:26 CET |
Vistin Pharma | Financial calendar | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 13 Nov 2020 12:46 CET |
Vistin Pharma | Vistin Pharma ASA: Meldepliktig handel | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 30 Oct 2020 07:30 CET |
Vistin Pharma | Vistin Pharma ASA: Third quarter and YTD 2020 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 26 Oct 2020 12:16 CET |
Vistin Pharma | Vistin Pharma ASA: Invitation to Q3 2020 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Aug 2020 17:00 CEST |
Vistin Pharma | Vistin Pharma ASA: Mandatory notification of trade | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 28 Aug 2020 07:30 CEST |
Vistin Pharma | Vistin Pharma ASA: Second quarter and first half 2020 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 21 Aug 2020 11:00 CEST |
Vistin Pharma | Vistin Pharma ASA: Invitation to second quarter and first half results conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 14 Jul 2020 15:38 CEST |
Vistin Pharma | Meldepliktig avslutning av aksjekjøp på termin i Vistin Pharma ASA | 20103015 Pharmaceuticals | Meldepliktig handel for primærinnsidere |